Advanced Search:
Equity Index Forex Crypto Commodity

ILMN - Illumina

$127.07  -3.63 (-2.78%)

Updated: 03:10 May 5, 2024 EST

Next Hour's AI Forecast

93.55%

Avg. Accuracy (AI)

$117.43

Next Session's AI Forecast

95.36%

Avg. Accuracy (AI)

$132.68

Next Week's AI Forecast

16.67%

Trend's Accuracy (AI)

$130.7

Illumina's Position Within the Diagnostics & Research Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

ILLUMINA - HISTORICAL DATA 6M

  • Last price

    $ 127.07

  • Daily change

    $ -3.63

  • Previous Close

    $ 130.7

  • Last Updated

    03:10 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-2.19 -0.87 -0.35 0.12 -0.25

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
2.78 2.1 1.96 2.21 2.03

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
0% 0% 0% 0%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
113.44 -5.41% 119.93 -3.99% 124.91 -1.48% 126.79

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.64 21.88 0.7 39.02

Illumina Technical Analysis News

Illumina

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500
https://www.illumina.com

Sectors: Healthcare
Industry: Diagnostics & Research
F. Time Employees: 10590
Description

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Corporate Governance

Illumina, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 10. The pillar scores are Audit: 9; Board: 8; Shareholder Rights: 6; Compensation: 10.

ILLUMINA'S HOLDERS RANK

List of holders with stock participation in Illumina.

Holder Rank Holder Shares Date Reported % Out Value